News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP
Photo of Dr. Hagop Kantarjian from obroncology.com
Jun 16, 2023, 19:38

Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP

In a post by Hagop Kantarjian on Twitter, it says, “Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP Georgina Gener-Ricos”

Article Link

Source: Hagop Kantarjian/Twitter

 

Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CPDasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP

 

Dasatinib Georgina Gener-Ricos Hagop Kantarjian
Special Coverage
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care
Blog
Feb 20, 2025, 10:52
Rob Winn: Our partners are what make the miracle medicines possible
Blog
Feb 20, 2025, 10:48
World Cancer Research Fund International's new policy blueprint to help policymakers reduce cancer risks - UICC
Blog
Feb 20, 2025, 10:45
Evaluating molecularly guided therapies beyond tumor type - ESMO
Blog
Feb 20, 2025, 10:41
Rasha Aboelhassan: Screening access is further limited by age and tobacco use history, which often excludes woman
Blog
Feb 20, 2025, 10:37
The first of Member Profile series - Lung Cancer Europe